nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ABCB11—bile duct—bile duct cancer	0.156	0.199	CbGeAlD
Paclitaxel—ABCB11—bile—bile duct cancer	0.12	0.153	CbGeAlD
Paclitaxel—ABCC2—bile duct—bile duct cancer	0.0792	0.101	CbGeAlD
Paclitaxel—ABCC2—bile—bile duct cancer	0.0609	0.0776	CbGeAlD
Paclitaxel—Docetaxel—EGFR—bile duct cancer	0.0353	1	CrCbGaD
Paclitaxel—MAP4—pancreas—bile duct cancer	0.0203	0.0259	CbGeAlD
Paclitaxel—NR1I2—liver—bile duct cancer	0.0197	0.0252	CbGeAlD
Paclitaxel—MAP2—pancreas—bile duct cancer	0.016	0.0204	CbGeAlD
Paclitaxel—MAP4—liver—bile duct cancer	0.0129	0.0165	CbGeAlD
Paclitaxel—MAPT—lymph node—bile duct cancer	0.0126	0.0161	CbGeAlD
Paclitaxel—TUBB4A—pancreas—bile duct cancer	0.0123	0.0157	CbGeAlD
Paclitaxel—TUBB2B—pancreas—bile duct cancer	0.0119	0.0152	CbGeAlD
Paclitaxel—SLCO1B3—liver—bile duct cancer	0.0113	0.0144	CbGeAlD
Paclitaxel—TUBB—pancreas—bile duct cancer	0.0113	0.0144	CbGeAlD
Paclitaxel—TUBB2A—pancreas—bile duct cancer	0.0112	0.0143	CbGeAlD
Paclitaxel—TUBB6—pancreas—bile duct cancer	0.0111	0.0141	CbGeAlD
Paclitaxel—MAP2—liver—bile duct cancer	0.0102	0.013	CbGeAlD
Paclitaxel—MAP4—lymph node—bile duct cancer	0.00989	0.0126	CbGeAlD
Paclitaxel—ABCB11—liver—bile duct cancer	0.00974	0.0124	CbGeAlD
Paclitaxel—TUBB4B—pancreas—bile duct cancer	0.00963	0.0123	CbGeAlD
Paclitaxel—CYP3A7—liver—bile duct cancer	0.00953	0.0122	CbGeAlD
Paclitaxel—BCL2—lymph node—bile duct cancer	0.00899	0.0115	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—liver—bile duct cancer	0.0081	0.0103	CbGeAlD
Paclitaxel—TUBB4A—liver—bile duct cancer	0.00785	0.01	CbGeAlD
Paclitaxel—MAP2—lymph node—bile duct cancer	0.00779	0.00994	CbGeAlD
Paclitaxel—TUBB—liver—bile duct cancer	0.00718	0.00916	CbGeAlD
Paclitaxel—TUBB2A—liver—bile duct cancer	0.00714	0.00911	CbGeAlD
Paclitaxel—TUBB6—liver—bile duct cancer	0.00705	0.00899	CbGeAlD
Paclitaxel—ABCC10—liver—bile duct cancer	0.00617	0.00787	CbGeAlD
Paclitaxel—TUBB4B—liver—bile duct cancer	0.00613	0.00781	CbGeAlD
Paclitaxel—TUBB4A—lymph node—bile duct cancer	0.00602	0.00768	CbGeAlD
Paclitaxel—TUBB2B—lymph node—bile duct cancer	0.00582	0.00742	CbGeAlD
Paclitaxel—TUBB—lymph node—bile duct cancer	0.00551	0.00702	CbGeAlD
Paclitaxel—TUBB2A—lymph node—bile duct cancer	0.00548	0.00699	CbGeAlD
Paclitaxel—TUBB6—lymph node—bile duct cancer	0.0054	0.00689	CbGeAlD
Paclitaxel—CYP3A5—pancreas—bile duct cancer	0.00527	0.00672	CbGeAlD
Paclitaxel—CYP19A1—liver—bile duct cancer	0.00519	0.00662	CbGeAlD
Paclitaxel—ABCC2—liver—bile duct cancer	0.00495	0.00632	CbGeAlD
Paclitaxel—CYP1B1—liver—bile duct cancer	0.00485	0.00619	CbGeAlD
Paclitaxel—ABCC10—lymph node—bile duct cancer	0.00473	0.00603	CbGeAlD
Paclitaxel—TUBB4B—lymph node—bile duct cancer	0.0047	0.00599	CbGeAlD
Paclitaxel—ABCC1—liver—bile duct cancer	0.00436	0.00557	CbGeAlD
Paclitaxel—CYP19A1—lymph node—bile duct cancer	0.00398	0.00508	CbGeAlD
Paclitaxel—ABCC2—lymph node—bile duct cancer	0.0038	0.00485	CbGeAlD
Paclitaxel—CYP1B1—lymph node—bile duct cancer	0.00372	0.00475	CbGeAlD
Paclitaxel—CYP2C8—liver—bile duct cancer	0.00372	0.00474	CbGeAlD
Paclitaxel—ABCG2—liver—bile duct cancer	0.00361	0.00461	CbGeAlD
Paclitaxel—CYP3A5—liver—bile duct cancer	0.00335	0.00428	CbGeAlD
Paclitaxel—ABCC1—lymph node—bile duct cancer	0.00335	0.00427	CbGeAlD
Paclitaxel—CYP2C9—liver—bile duct cancer	0.0033	0.00421	CbGeAlD
Paclitaxel—ABCB1—pancreas—bile duct cancer	0.0028	0.00357	CbGeAlD
Paclitaxel—ABCG2—lymph node—bile duct cancer	0.00277	0.00353	CbGeAlD
Paclitaxel—CYP3A4—liver—bile duct cancer	0.00252	0.00321	CbGeAlD
Paclitaxel—ABCB1—liver—bile duct cancer	0.00178	0.00227	CbGeAlD
Paclitaxel—ABCB1—lymph node—bile duct cancer	0.00137	0.00174	CbGeAlD
Paclitaxel—MAP2—SIDS Susceptibility Pathways—IL6—bile duct cancer	0.0008	0.00443	CbGpPWpGaD
Paclitaxel—BCL2—Interleukin-11 Signaling Pathway—HRAS—bile duct cancer	0.000793	0.00439	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—KRAS—bile duct cancer	0.000792	0.00438	CbGpPWpGaD
Paclitaxel—ABCC1—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000789	0.00437	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000787	0.00435	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—MUC2—bile duct cancer	0.000785	0.00434	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—MUC2—bile duct cancer	0.000785	0.00434	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—MUC1—bile duct cancer	0.000778	0.0043	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—MUC4—bile duct cancer	0.000778	0.0043	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—MET—bile duct cancer	0.000773	0.00427	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—HGF—bile duct cancer	0.000767	0.00424	CbGpPWpGaD
Paclitaxel—CYP1B1—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000763	0.00422	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—MUC2—bile duct cancer	0.000758	0.00419	CbGpPWpGaD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.000756	0.00419	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—MBD2—bile duct cancer	0.000744	0.00412	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—MUC2—bile duct cancer	0.000734	0.00406	CbGpPWpGaD
Paclitaxel—BCL2—IL-3 Signaling Pathway—HRAS—bile duct cancer	0.000728	0.00403	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—MUC2—bile duct cancer	0.000718	0.00397	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000716	0.00396	CbGpPWpGaD
Paclitaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000715	0.00396	CbGpPWpGaD
Paclitaxel—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—bile duct cancer	0.000705	0.0039	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.0007	0.00388	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—ERBB2—bile duct cancer	0.00069	0.00382	CbGpPWpGaD
Paclitaxel—BCL2—IL2-mediated signaling events—HRAS—bile duct cancer	0.000674	0.00373	CbGpPWpGaD
Paclitaxel—ABCC10—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000658	0.00364	CbGpPWpGaD
Paclitaxel—ABCC2—NRF2 pathway—TGFBR2—bile duct cancer	0.000654	0.00362	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—NRAS—bile duct cancer	0.000647	0.00358	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—MUC2—bile duct cancer	0.000645	0.00357	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—MMP2—bile duct cancer	0.000644	0.00357	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000635	0.00351	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—bile duct cancer	0.000632	0.0035	CbGpPWpGaD
Paclitaxel—BCL2—Kit receptor signaling pathway—HRAS—bile duct cancer	0.000627	0.00347	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—SMAD4—bile duct cancer	0.000621	0.00344	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—FAR2—bile duct cancer	0.000615	0.0034	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—MET—bile duct cancer	0.000605	0.00335	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—NRAS—bile duct cancer	0.000604	0.00334	CbGpPWpGaD
Paclitaxel—ABCC2—NRF2 pathway—HGF—bile duct cancer	0.000601	0.00333	CbGpPWpGaD
Paclitaxel—BCL2—ATF-2 transcription factor network—IL6—bile duct cancer	0.000601	0.00332	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—bile duct cancer	0.000598	0.00331	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00059	0.00326	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—MUC2—bile duct cancer	0.00059	0.00326	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00058	0.00321	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.000578	0.0032	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000578	0.0032	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—FAR2—bile duct cancer	0.000578	0.0032	CbGpPWpGaD
Paclitaxel—ABCG2—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000576	0.00319	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TGFB1—bile duct cancer	0.000561	0.0031	CbGpPWpGaD
Paclitaxel—BCL2—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.000559	0.00309	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—KRAS—bile duct cancer	0.000556	0.00308	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—EGFR—bile duct cancer	0.00055	0.00304	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.000549	0.00304	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000546	0.00302	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000545	0.00302	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000536	0.00296	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000536	0.00296	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000533	0.00295	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—NRAS—bile duct cancer	0.000525	0.0029	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—KRAS—bile duct cancer	0.00052	0.00288	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000517	0.00286	CbGpPWpGaD
Paclitaxel—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bile duct cancer	0.000507	0.0028	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000506	0.0028	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TGFB1—bile duct cancer	0.000503	0.00278	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000501	0.00277	CbGpPWpGaD
Paclitaxel—MAPT—BDNF signaling pathway—HRAS—bile duct cancer	0.0005	0.00277	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000496	0.00275	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—bile duct cancer	0.000495	0.00274	CbGpPWpGaD
Paclitaxel—MAPT—Apoptosis—TP53—bile duct cancer	0.000493	0.00273	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00049	0.00271	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—bile duct cancer	0.000488	0.0027	CbGpPWpGaD
Paclitaxel—BCL2—C-MYB transcription factor network—HRAS—bile duct cancer	0.000473	0.00262	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000469	0.0026	CbGpPWpGaD
Paclitaxel—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.000465	0.00257	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis Modulation and Signaling—TP53—bile duct cancer	0.000464	0.00257	CbGpPWpGaD
Paclitaxel—MAPT—MAPK Signaling Pathway—TP53—bile duct cancer	0.000462	0.00256	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—KRAS—bile duct cancer	0.000452	0.0025	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—ERBB2—bile duct cancer	0.000442	0.00245	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00044	0.00244	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00044	0.00243	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—FAR2—bile duct cancer	0.000436	0.00241	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—FAR2—bile duct cancer	0.000435	0.0024	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000434	0.0024	CbGpPWpGaD
Paclitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000431	0.00238	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.000431	0.00238	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—FAR2—bile duct cancer	0.00042	0.00233	CbGpPWpGaD
Paclitaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000417	0.00231	CbGpPWpGaD
Paclitaxel—TUBB2B—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000416	0.0023	CbGpPWpGaD
Paclitaxel—TUBB6—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000416	0.0023	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—TP53—bile duct cancer	0.000414	0.00229	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000412	0.00228	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00041	0.00227	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.000409	0.00226	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000402	0.00223	CbGpPWpGaD
Paclitaxel—TUBB3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000402	0.00222	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—bile duct cancer	0.000402	0.00222	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000396	0.00219	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—HRAS—bile duct cancer	0.000396	0.00219	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—EGFR—bile duct cancer	0.000391	0.00217	CbGpPWpGaD
Paclitaxel—TUBB2A—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000389	0.00215	CbGpPWpGaD
Paclitaxel—BCL2—DNA Damage Response (only ATM dependent)—HRAS—bile duct cancer	0.000384	0.00212	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—FAR2—bile duct cancer	0.000382	0.00212	CbGpPWpGaD
Paclitaxel—TUBB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000381	0.00211	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—FAR2—bile duct cancer	0.000379	0.0021	CbGpPWpGaD
Paclitaxel—BCL2—Senescence and Autophagy in Cancer—IL6—bile duct cancer	0.000379	0.0021	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.000368	0.00204	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000364	0.00201	CbGpPWpGaD
Paclitaxel—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000351	0.00194	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.000348	0.00193	CbGpPWpGaD
Paclitaxel—TUBB4A—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000342	0.00189	CbGpPWpGaD
Paclitaxel—BCL2—Direct p53 effectors—TP53—bile duct cancer	0.000329	0.00182	CbGpPWpGaD
Paclitaxel—TUBB4B—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000313	0.00173	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000311	0.00172	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.000309	0.00171	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—EGFR—bile duct cancer	0.000307	0.0017	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.000305	0.00169	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—TP53—bile duct cancer	0.000303	0.00168	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—IDH2—bile duct cancer	0.0003	0.00166	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—SMAD4—bile duct cancer	0.000299	0.00166	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000288	0.0016	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000282	0.00156	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—IDH2—bile duct cancer	0.000282	0.00156	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—FAR2—bile duct cancer	0.000274	0.00152	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00026	0.00144	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—IDH1—bile duct cancer	0.000258	0.00143	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000257	0.00142	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000256	0.00142	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—RNF43—bile duct cancer	0.000253	0.0014	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—HRAS—bile duct cancer	0.000246	0.00136	CbGpPWpGaD
Paclitaxel—ABCC2—NRF2 pathway—TGFB1—bile duct cancer	0.000245	0.00136	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—IDH1—bile duct cancer	0.000243	0.00134	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—FAR2—bile duct cancer	0.000237	0.00131	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—MMP2—bile duct cancer	0.000237	0.00131	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—MMP2—bile duct cancer	0.000237	0.00131	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000235	0.0013	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bile duct cancer	0.000232	0.00128	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—MMP2—bile duct cancer	0.000229	0.00127	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000226	0.00125	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000224	0.00124	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—MMP2—bile duct cancer	0.000222	0.00123	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—KRAS—bile duct cancer	0.000219	0.00121	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IDH1—bile duct cancer	0.000218	0.00121	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—MMP2—bile duct cancer	0.000217	0.0012	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—IDH2—bile duct cancer	0.000213	0.00118	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—IDH2—bile duct cancer	0.000212	0.00117	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—FAR2—bile duct cancer	0.000207	0.00114	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—IDH2—bile duct cancer	0.000205	0.00114	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000202	0.00112	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.0002	0.00111	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—bile duct cancer	0.000195	0.00108	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—MMP2—bile duct cancer	0.000195	0.00108	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—FAR2—bile duct cancer	0.000193	0.00107	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	0.000188	0.00104	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—IDH2—bile duct cancer	0.000187	0.00103	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—IDH2—bile duct cancer	0.000185	0.00102	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HGF—bile duct cancer	0.000184	0.00102	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—IDH1—bile duct cancer	0.000183	0.00101	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—IDH1—bile duct cancer	0.000182	0.00101	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000182	0.00101	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—ERBB2—bile duct cancer	0.000182	0.00101	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—MMP2—bile duct cancer	0.000178	0.000985	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—IDH1—bile duct cancer	0.000176	0.000977	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000176	0.000972	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—SLC5A5—bile duct cancer	0.00017	0.000942	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—IDH1—bile duct cancer	0.000161	0.000888	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—SLC5A5—bile duct cancer	0.00016	0.000887	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.00016	0.000883	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—IDH1—bile duct cancer	0.000159	0.000881	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.00015	0.000831	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—bile duct cancer	0.000144	0.000796	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NRAS—bile duct cancer	0.000138	0.000766	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—IDH2—bile duct cancer	0.000134	0.00074	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GNAS—bile duct cancer	0.000132	0.000732	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000131	0.000727	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.000129	0.000711	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FAR2—bile duct cancer	0.000127	0.000705	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EGFR—bile duct cancer	0.000126	0.000698	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GNAS—bile duct cancer	0.000125	0.000689	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000122	0.000677	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—SLC5A5—bile duct cancer	0.000121	0.000669	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—SLC5A5—bile duct cancer	0.00012	0.000666	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—bile duct cancer	0.000119	0.000659	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—KRAS—bile duct cancer	0.000119	0.000659	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SLC5A5—bile duct cancer	0.000116	0.000644	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—IDH2—bile duct cancer	0.000116	0.000641	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFBR2—bile duct cancer	0.000116	0.000641	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—IDH1—bile duct cancer	0.000115	0.000637	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000113	0.000627	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000113	0.000624	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SMAD4—bile duct cancer	0.00011	0.000606	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000109	0.000604	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—bile duct cancer	0.000109	0.000603	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ERBB2—bile duct cancer	0.000106	0.000586	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SLC5A5—bile duct cancer	0.000106	0.000586	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SLC5A5—bile duct cancer	0.000105	0.000581	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HRAS—bile duct cancer	0.000101	0.00056	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—IDH2—bile duct cancer	0.000101	0.000559	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—IDH1—bile duct cancer	9.96e-05	0.000551	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IL6—bile duct cancer	9.69e-05	0.000536	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	9.5e-05	0.000526	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—IDH2—bile duct cancer	9.43e-05	0.000522	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GNAS—bile duct cancer	9.4e-05	0.00052	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GNAS—bile duct cancer	9.35e-05	0.000518	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	9.29e-05	0.000514	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	9.11e-05	0.000504	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GNAS—bile duct cancer	9.05e-05	0.000501	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—IDH1—bile duct cancer	8.68e-05	0.00048	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	8.61e-05	0.000476	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GNAS—bile duct cancer	8.23e-05	0.000455	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GNAS—bile duct cancer	8.16e-05	0.000451	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NOS2—bile duct cancer	8.16e-05	0.000451	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—IDH1—bile duct cancer	8.11e-05	0.000449	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—bile duct cancer	8.06e-05	0.000446	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	7.65e-05	0.000423	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC5A5—bile duct cancer	7.59e-05	0.00042	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—bile duct cancer	7.34e-05	0.000406	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—bile duct cancer	7.11e-05	0.000393	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—bile duct cancer	6.94e-05	0.000384	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—bile duct cancer	6.69e-05	0.00037	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC5A5—bile duct cancer	6.57e-05	0.000364	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—IDH2—bile duct cancer	6.22e-05	0.000344	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	6.16e-05	0.000341	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—bile duct cancer	6.13e-05	0.000339	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—bile duct cancer	6e-05	0.000332	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNAS—bile duct cancer	5.9e-05	0.000326	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—bile duct cancer	5.9e-05	0.000326	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC5A5—bile duct cancer	5.73e-05	0.000317	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—bile duct cancer	5.64e-05	0.000312	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC5A5—bile duct cancer	5.35e-05	0.000296	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—IDH1—bile duct cancer	5.35e-05	0.000296	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNAS—bile duct cancer	5.11e-05	0.000283	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—bile duct cancer	5.05e-05	0.000279	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—bile duct cancer	5.02e-05	0.000278	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	5.01e-05	0.000277	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—bile duct cancer	4.86e-05	0.000269	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—bile duct cancer	4.67e-05	0.000258	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNAS—bile duct cancer	4.45e-05	0.000246	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—bile duct cancer	4.42e-05	0.000245	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—bile duct cancer	4.38e-05	0.000242	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—bile duct cancer	4.34e-05	0.00024	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—bile duct cancer	4.25e-05	0.000235	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNAS—bile duct cancer	4.16e-05	0.00023	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—bile duct cancer	4.02e-05	0.000222	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC5A5—bile duct cancer	3.53e-05	0.000195	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—bile duct cancer	3.41e-05	0.000189	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—bile duct cancer	3.27e-05	0.000181	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—bile duct cancer	3.17e-05	0.000175	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—bile duct cancer	2.74e-05	0.000152	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNAS—bile duct cancer	2.74e-05	0.000152	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—bile duct cancer	2.39e-05	0.000132	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—bile duct cancer	2.23e-05	0.000124	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—bile duct cancer	1.47e-05	8.15e-05	CbGpPWpGaD
